CsPbBr 3 Perovskite Nanoparticles causes Colitis‐Like Symptom via Promoting Intestinal Barrier Damage and Gut Microbiota Dysbiosis
Small · 2023
DOI: 10.1002/smll.202301129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Linqiang Mei und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, 10…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lead‐based perovskite nanoparticles (Pb‐PNPs) with superior optoelectronic properties are promising alternatives for the next generation of photovoltaics materials. This raises a great concern about their potential exposure toxicity in biological systems. However, little is known about their adverse effects on the gastrointestinal tract system so far. Here, the aim is to investigate the biodistribution, biotransformation, potential gastrointestinal tract toxicity, and effect on the gut microbiota after oral exposure to the CsPbBr 3 perovskite nanoparticles (CPB PNPs). The advanced synchrotron radiation based microscopic X‐ray fluorescence scanning and X‐ray absorption near‐edge spectroscopy demonstrate that high doses of CPB (CPB‐H) PNPs can gradually transform into different lead‐based compounds, subsequently accumulating in the gastrointestinal tract, especially the colon. Meanwhile, the pathological changes of stomach, small intestine, and colon reveal that CPB‐H PNPs have higher gastrointestinal tract toxicity than Pb(Ac) 2 , consequently leading to colitis‐like symptoms. More importantly, 16S rRNA gene sequencing analysis discloses that CPB‐H PNPs cause more significant alterations in the richness and diversity of the gut microbiota related to inflammation, intestinal barrier, and immune function than Pb(Ac) 2 . The findings may contribute to shedding light on understanding the adverse effects on gastrointestinal tract and gut microbiota of Pb‐PNPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Center of Materials Science and Optoelectronics Engineering, College of Materials Science and Optoelectronic Technology, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Academician Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, P. R. China.
ORCID-Profile: Linqiang Mei, Zhanjun Gu
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Mei, L., Guo, J., He, R., Ding, X., Yin, W., & Gu, Z. (2023). CsPbBr 3 Perovskite Nanoparticles causes Colitis‐Like Symptom via Promoting Intestinal Barrier Damage and Gut Microbiota Dysbiosis. Small. https://doi.org/10.1002/smll.202301129
Vancouver
Mei L, Guo J, He R, Ding X, Yin W, Gu Z. CsPbBr 3 Perovskite Nanoparticles causes Colitis‐Like Symptom via Promoting Intestinal Barrier Damage and Gut Microbiota Dysbiosis. Small. 2023. doi:10.1002/smll.202301129
BibTeX
@article{Mei2023,
author = {Mei, Linqiang and Guo, Junsong and He, Rendong and Ding, Xuefeng and Yin, Wenyan and Gu, Zhanjun},
title = {CsPbBr 3 Perovskite Nanoparticles causes Colitis‐Like Symptom via Promoting Intestinal Barrier Damage and Gut Microbiota Dysbiosis},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202301129}
}
EUVIMED